FEXOFENADINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fexofenadine, and what generic alternatives are available?
Fexofenadine is a drug marketed by Barr, Aurobindo Pharma Ltd, P And L, Contract Pharmacal, Dr Reddys, Dr Reddys Labs Ltd, L Perrigo Co, Rising, Teva, Granules, Hetero Labs Ltd V, Sciegen Pharms, Sun Pharm Inds, Time Cap Labs, Unique, Aurobindo Pharma, Impax Pharms, and Sun Pharm. and is included in twenty-six NDAs.
The generic ingredient in FEXOFENADINE is fexofenadine hydrochloride; pseudoephedrine hydrochloride. There are two drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the fexofenadine hydrochloride; pseudoephedrine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fexofenadine
A generic version of FEXOFENADINE was approved as fexofenadine hydrochloride; pseudoephedrine hydrochloride by DR REDDYS LABS LTD on June 22nd, 2011.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FEXOFENADINE?
- What are the global sales for FEXOFENADINE?
- What is Average Wholesale Price for FEXOFENADINE?
Summary for FEXOFENADINE
| US Patents: | 0 |
| Applicants: | 18 |
| NDAs: | 26 |
| Drug Prices: | Drug price information for FEXOFENADINE |
| Drug Sales Revenues: | Drug sales revenues for FEXOFENADINE |
| DailyMed Link: | FEXOFENADINE at DailyMed |



